TNM001

· Zhuhai Trinomab Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TNM001, covering 2024-06-28 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: A Sudy to Evaluate the Efficacy and Safety of TNM001 in High-risk Infants [Phase 3]